XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of €6.99 million as of December 5, 2025. Its market cap has decreased by -65.14% in one year.

Market Cap

6.99M

Enterprise Value

6.03M

Revenue

435.62K

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.68

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 144.96M to 6.99M, a decrease of -95.18%. That is a compound annual growth rate of -13.89%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	6.99M	-67.65%
Dec 31, 2024	21.62M	351.29%
Dec 31, 2023	4.79M	-19.50%
Dec 29, 2022	5.95M	-55.04%
Dec 30, 2021	13.24M	3.31%
Dec 31, 2020	12.81M	105.53%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	244.97B
Siemens Aktiengesellschaft	177.09B
Allianz SE	138.86B
Deutsche Telekom AG	129.48B
Siemens Energy AG	97.17B
Rheinmetall AG	69.69B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.36B
Deutsche Bank Aktiengesellschaft	58.94B

Market Cap Rankings